Literature DB >> 26513235

Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis.

N Mørk1, E Kofod-Olsen2, K B Sørensen1, E Bach1, T F Ørntoft3, L Østergaard1,2, S R Paludan4, M Christiansen2,5, T H Mogensen1,2,4.   

Abstract

Herpes simplex encephalitis (HSE) in children has previously been linked to defects in type I interferon production downstream of Toll-like receptor (TLR)3. In the present study, we used whole-exome sequencing to investigate the genetic profile of 16 adult patients with a history of HSE. We identified novel mutations in IRF3, TYK2 and MAVS, molecules involved in generating innate antiviral immune responses, which have not previously been associated with HSE. Moreover, data revealed mutations in TLR3, TRIF, TBK1 and STAT1 known to be associated with HSE in children but not previously described in adults. All discovered mutations were heterozygous missense mutations, the majority of which were associated with significantly decreased antiviral responses to HSV-1 infection and/or the TLR3 agonist poly(I:C) in patient peripheral blood mononuclear cells compared with controls. Altogether, this study demonstrates novel mutations in the TLR3 signaling pathway in molecules previously identified in children, suggesting that impaired innate immunity to HSV-1 may also increase susceptibility to HSE in adults. Importantly, the identification of mutations in innate signaling molecules not directly involved in TLR3 signaling suggests the existence of innate immunodeficiencies predisposing to HSE beyond the TLR3 pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26513235     DOI: 10.1038/gene.2015.46

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  44 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

3.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

4.  Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.

Authors:  Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Lazaro Lorenzo; Rabih Halwani; Abdullah Alangari; Elisabeth Israelsson; Sylvie Fabrega; Annabelle Cardon; Jerome Maluenda; Megumi Tatematsu; Farhad Mahvelati; Melina Herman; Michael Ciancanelli; Yiqi Guo; Zobaida AlSum; Nouf Alkhamis; Abdulkarim S Al-Makadma; Ata Ghadiri; Soraya Boucherit; Sabine Plancoulaine; Capucine Picard; Flore Rozenberg; Marc Tardieu; Pierre Lebon; Emmanuelle Jouanguy; Nima Rezaei; Tsukasa Seya; Misako Matsumoto; Damien Chaussabel; Anne Puel; Shen-Ying Zhang; Laurent Abel; Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

Review 5.  Immunodeficiency mutation databases (IDbases).

Authors:  Hilkka Piirilä; Jouni Väliaho; Mauno Vihinen
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

6.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Authors:  Yoshiyuki Minegishi; Masako Saito; Tomohiro Morio; Ken Watanabe; Kazunaga Agematsu; Shigeru Tsuchiya; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Hideo Kaneko; Naomi Kondo; Ikuya Tsuge; Akihiro Yachie; Yukio Sakiyama; Tsutomu Iwata; Fumio Bessho; Tsutomu Ohishi; Kosuke Joh; Kohsuke Imai; Kazuhiro Kogawa; Miwa Shinohara; Mikiya Fujieda; Hiroshi Wakiguchi; Srdjan Pasic; Mario Abinun; Hans D Ochs; Eleonore D Renner; Annette Jansson; Bernd H Belohradsky; Ayse Metin; Norio Shimizu; Shuki Mizutani; Toshio Miyawaki; Shigeaki Nonoyama; Hajime Karasuyama
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

7.  Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

Authors:  Stéphanie Dupuis; Emmanuelle Jouanguy; Sami Al-Hajjar; Claire Fieschi; Ibrahim Zaid Al-Mohsen; Suliman Al-Jumaah; Kun Yang; Ariane Chapgier; Céline Eidenschenk; Pierre Eid; Abdulaziz Al Ghonaium; Haysam Tufenkeji; Husn Frayha; Suleiman Al-Gazlan; Hassan Al-Rayes; Robert D Schreiber; Ion Gresser; Jean-Laurent Casanova
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

8.  Cell type-dependent requirement of autophagy in HSV-1 antiviral defense.

Authors:  Brian Yordy; Akiko Iwasaki
Journal:  Autophagy       Date:  2012-10-24       Impact factor: 16.016

9.  Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies.

Authors:  Jean-Laurent Casanova; Mary Ellen Conley; Stephen J Seligman; Laurent Abel; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2014-10-13       Impact factor: 14.307

10.  Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood.

Authors:  Melina Herman; Michael Ciancanelli; Yi-Hung Ou; Lazaro Lorenzo; Maja Klaudel-Dreszler; Elodie Pauwels; Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Avinash Abhyankar; Elisabeth Israelsson; Yiqi Guo; Annabelle Cardon; Flore Rozenberg; Pierre Lebon; Marc Tardieu; Edyta Heropolitanska-Pliszka; Damien Chaussabel; Michael A White; Laurent Abel; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2012-07-30       Impact factor: 14.307

View more
  32 in total

Review 1.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

Review 2.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

Review 3.  Herpes Simplex Encephalitis: an Update.

Authors:  John W Gnann; Richard J Whitley
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

Review 4.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

5.  Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.

Authors:  Zachary M Parker; Tracy Jo Pasieka; George A Parker; David A Leib
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 6.  Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity.

Authors:  Shen-Ying Zhang
Journal:  Hum Genet       Date:  2020-02-10       Impact factor: 4.132

Review 7.  Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases).

Authors:  Annely M Richardson; Ann M Moyer; Linda Hasadsri; Roshini S Abraham
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

Review 8.  Neuron-intrinsic immunity to viruses in mice and humans.

Authors:  Shen-Ying Zhang; Oliver Harschnitz; Lorenz Studer; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2021-08-20       Impact factor: 7.268

Review 9.  Lessons learned from the study of human inborn errors of innate immunity.

Authors:  Giorgia Bucciol; Leen Moens; Barbara Bosch; Xavier Bossuyt; Jean-Laurent Casanova; Anne Puel; Isabelle Meyts
Journal:  J Allergy Clin Immunol       Date:  2018-08-01       Impact factor: 10.793

10.  Nuclear ADP-ribosylation drives IFNγ-dependent STAT1α enhancer formation in macrophages.

Authors:  Rebecca Gupte; Tulip Nandu; W Lee Kraus
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.